Valley Manor Rehabilitation And Healthcare Center | |
7650 Route 309, Coopersburg, Pennsylvania 18036 | |
(610) 282-1919 | |
Name | Valley Manor Rehabilitation And Healthcare Center |
---|---|
Location | 7650 Route 309, Coopersburg, Pennsylvania |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 180 |
Occupancy Rate | 75.89% |
Medicare ID (CCN) | 395167 |
Legal Business Name | Valley Manor Operations Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1073684668 |
Organization Name | NORTHERN HEALTH FACILITIES, INC. |
Doing Business As | VALLEY MANOR NURSING AND REHABILITATION CENTER |
Address | 7650 Route 309, Coopersburg, PA 18036 |
Phone Number | 610-282-1919 |
News Archive
Researchers at UCLA's Jonsson Comprehensive Cancer Center led by Dr. Karim Chamie have found that more intense surveillance and treatment of bladder cancer in the first two years after diagnosis could reduce the number of patients whose cancer returns after treatment and lower the disease's death rate. The study was published online ahead of press today in the journal Cancer.
As the partial government shutdown drags on, about 800,000 federal employees who work for the shuttered agencies — and their families — are facing the reality of life without a paycheck.
Bibby Scientific Ltd announced today that Stuart®, a leading UK manufacturer of laboratory benchtop equipment, has launched a new range of Undergrad hotplate stirrer kits that offer excellent value for money for a broad range of life science heating and stirring applications.
Acucela Inc., a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).
› Verified 8 days ago
NPI Number | 1124535174 |
Organization Name | VALLEY MANOR OPERATIONS LLC |
Doing Business As | VALLEY MANOR REHABILITATION AND HEALTHCARE CENTER |
Address | 7650 Route 309, Coopersburg, PA 18036 |
Phone Number | 610-282-1919 |
News Archive
Researchers at UCLA's Jonsson Comprehensive Cancer Center led by Dr. Karim Chamie have found that more intense surveillance and treatment of bladder cancer in the first two years after diagnosis could reduce the number of patients whose cancer returns after treatment and lower the disease's death rate. The study was published online ahead of press today in the journal Cancer.
As the partial government shutdown drags on, about 800,000 federal employees who work for the shuttered agencies — and their families — are facing the reality of life without a paycheck.
Bibby Scientific Ltd announced today that Stuart®, a leading UK manufacturer of laboratory benchtop equipment, has launched a new range of Undergrad hotplate stirrer kits that offer excellent value for money for a broad range of life science heating and stirring applications.
Acucela Inc., a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).
› Verified 8 days ago
NPI Number | 1679961999 |
Organization Name | OAK HRC VALLEY MANOR LLC |
Doing Business As | VALLEY MANOR HEALTH AND REHABILITATION CENTER |
Address | 7650 Route 309, Coopersburg, PA 18036 |
Phone Number | 610-282-1919 |
News Archive
Researchers at UCLA's Jonsson Comprehensive Cancer Center led by Dr. Karim Chamie have found that more intense surveillance and treatment of bladder cancer in the first two years after diagnosis could reduce the number of patients whose cancer returns after treatment and lower the disease's death rate. The study was published online ahead of press today in the journal Cancer.
As the partial government shutdown drags on, about 800,000 federal employees who work for the shuttered agencies — and their families — are facing the reality of life without a paycheck.
Bibby Scientific Ltd announced today that Stuart®, a leading UK manufacturer of laboratory benchtop equipment, has launched a new range of Undergrad hotplate stirrer kits that offer excellent value for money for a broad range of life science heating and stirring applications.
Acucela Inc., a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).
› Verified 8 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Researchers at UCLA's Jonsson Comprehensive Cancer Center led by Dr. Karim Chamie have found that more intense surveillance and treatment of bladder cancer in the first two years after diagnosis could reduce the number of patients whose cancer returns after treatment and lower the disease's death rate. The study was published online ahead of press today in the journal Cancer.
As the partial government shutdown drags on, about 800,000 federal employees who work for the shuttered agencies — and their families — are facing the reality of life without a paycheck.
Bibby Scientific Ltd announced today that Stuart®, a leading UK manufacturer of laboratory benchtop equipment, has launched a new range of Undergrad hotplate stirrer kits that offer excellent value for money for a broad range of life science heating and stirring applications.
Acucela Inc., a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).
› Verified 8 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 28.02 | 14.46 |
Percentage of long-stay residents who lose too much weight | 10.8 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 39.3 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.74 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.45 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 1.62 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.56 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 95.09 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 23.73 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 84.86 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.79 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 40.5 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 33.7 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 7.89 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 67.46 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.08 | 82.93 |
News Archive
Researchers at UCLA's Jonsson Comprehensive Cancer Center led by Dr. Karim Chamie have found that more intense surveillance and treatment of bladder cancer in the first two years after diagnosis could reduce the number of patients whose cancer returns after treatment and lower the disease's death rate. The study was published online ahead of press today in the journal Cancer.
As the partial government shutdown drags on, about 800,000 federal employees who work for the shuttered agencies — and their families — are facing the reality of life without a paycheck.
Bibby Scientific Ltd announced today that Stuart®, a leading UK manufacturer of laboratory benchtop equipment, has launched a new range of Undergrad hotplate stirrer kits that offer excellent value for money for a broad range of life science heating and stirring applications.
Acucela Inc., a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).
› Verified 8 days ago
Valley Manor Rehabilitation And Healthcare Center Location: 7650 Route 309, Coopersburg, Pennsylvania 18036 Phone: (610) 282-1919 |